Sakar Healthcare has received European Union (EU) GMP approval for Small Volume Parenteral (SVP) manufacturing unit of liquid injections and Lyophilised injections to manufacture and supply products to Europe and other developed countries, as the regulatory body has issued the Certificate.
With this approval Sakar is now prepared to export the diverse product portfolio across 30 countries in Europe and other developed countries worldwide. The certification will enable Sakar to reach and cater to the growing needs of patients in the EU markets and provide affordable and innovative medicines in coming years.
Sakar Healthcare is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. Its Product domestic sales are generally exported by third party.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: